InvestorsHub Logo
Followers 19
Posts 3234
Boards Moderated 1
Alias Born 06/05/2020

Re: PennyWorld post# 44587

Sunday, 02/05/2023 8:13:02 PM

Sunday, February 05, 2023 8:13:02 PM

Post# of 44690
As part of the FDA's Coronavirus Treatment Acceleration Program, Relief Therapeutics, a Swiss company, is examining the effectiveness of Aviptadil, a patented synthetic
version of a human vasoactive intestinal polypeptide (VIP), for
COVID-19-related ARDS at New York University Langone (NYU Langone Health)
(CTAP).